| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
7,232 |
6,385 |
$604K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,183 |
1,069 |
$145K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
424 |
370 |
$41K |
| 90686 |
|
1,415 |
1,297 |
$30K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
186 |
176 |
$19K |
| 87428 |
|
621 |
547 |
$18K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
344 |
327 |
$17K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
120 |
117 |
$13K |
| 96127 |
|
3,263 |
1,931 |
$12K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,619 |
1,284 |
$12K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
670 |
607 |
$11K |
| 96160 |
|
5,543 |
4,207 |
$10K |
| 92551 |
|
641 |
599 |
$6K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,888 |
1,664 |
$5K |
| 0072A |
|
89 |
84 |
$3K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
28 |
25 |
$3K |
| 0071A |
|
88 |
77 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
273 |
230 |
$2K |
| G0136 |
Administration of a standardized, evidence-based assessment of physical activity and nutrition, 5-15 minutes, not more often than every 6 months |
319 |
304 |
$2K |
| 90656 |
|
73 |
73 |
$2K |
| 0001A |
|
35 |
30 |
$1K |
| 90670 |
|
29 |
25 |
$835.42 |
| 0002A |
|
17 |
17 |
$680.00 |
| W7010 |
|
43 |
40 |
$668.07 |
| 87420 |
|
46 |
41 |
$421.16 |
| 90677 |
|
18 |
15 |
$419.04 |
| 87070 |
|
100 |
83 |
$369.78 |
| S8301 |
Infection control supplies, not otherwise specified |
320 |
296 |
$336.00 |
| D1206 |
Topical application of fluoride varnish |
13 |
13 |
$323.96 |
| 90697 |
|
13 |
13 |
$302.64 |
| 90680 |
|
16 |
13 |
$302.64 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
31 |
14 |
$301.56 |
| 90661 |
|
14 |
14 |
$256.08 |
| 87807 |
|
34 |
29 |
$255.07 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
177 |
119 |
$143.75 |
| 99072 |
|
3,369 |
2,932 |
$141.00 |
| 94760 |
|
249 |
216 |
$140.40 |
| 99173 |
|
63 |
61 |
$101.72 |
| W7000 |
|
14 |
12 |
$61.68 |
| 99051 |
|
14 |
13 |
$59.26 |
| 85018 |
|
12 |
12 |
$11.65 |
| 36416 |
|
85 |
67 |
$3.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
30 |
27 |
$0.00 |
| 99000 |
|
37 |
30 |
$0.00 |
| G9920 |
Screening performed and negative |
960 |
916 |
$0.00 |